. Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study 1 Introduction Sorafenib is the only systemic…
Hepatobiliary Malignancy Program Treatment of Biliary Cancers Abby B. Siegel, MD, MS Columbia University Co-Chair, SWOG Hepatobiliary Committee NCI Task Force, Hepatobiliary…
NCCN Guidelines for Patients Gallbladder and Bile Duct CancersHepatobiliary Cancers 1 NCCN Guidelines for Patients® Gallbladder and Bile Duct Cancers, 2021 Gallbladder